AndreaBozzo/ceres-open-data-index huggingface dataset:
Weekly Cumulative RSV Vaccination Coverage and Intent, Overall, by Selected Demographics and Jurisdiction, Among Adults 75 and Older and 50-74 Years with High-Risk Conditions Ever Vaccinated, United States

• Weekly Cumulative RSV Vaccination Coverage and Intent Among Adults 75 Years and Older and 50-74 Years with High Risk Conditions Ever Vaccinated with RSV Vaccine by Demographic Characteristics and Jurisdiction • Weekly estimates of RSV vaccination coverage and intent among adults 75 years and older and 50-74 years with high risk conditions are calculated using data from National Immunization Surveys (NIS) – Fall Respiratory Virus Module (NIS–FRVM). The NIS-FRVM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older. • In June 2025, the Advisory Committee on Immunization Practices (ACIP) voted to recommend that adults aged 50–74 years who are at increased risk for severe RSV disease may receive a single dose of an RSV vaccine. In June 2024, the ACIP voted to recommend a single dose of RSV vaccine for all adults 75 years and older. The data below capture ever receiving a dose of an RSV vaccine by adults 50 years and older. • The NIS-FRVM data posted on the dashboard below are currently a few days behind the data that are posted on the Respiratory Illnesses Data Channel. This lag is due to the time it takes to review data by geographic and sociodemographic characteristics and summarize the findings.
Weekly Cumulative Percentage of Children Ages 6 Months -17 Years who are up to date with the updated 2023-24 COVID-19 Vaccine, by Jurisdiction

• Weekly COVID-19 vaccination coverage estimates among children 6 months to 17 years is assessed through the National Immunization Survey (https://www.cdc.gov/vaccines/imz-managers/nis/about.html). • Weekly estimates of COVID-19 vaccination coverage among children through December 31, 2023, were calculated using data from the National Immunization Survey-Child COVID Module (NIS-CCM) (https://www.cdc.gov/vaccines/imz-managers/nis/about.html#nis-ccm). Beginning January 2, 2024, the NIS-CCM was discontinued, and questions regarding receipt of COVID-19 vaccination among children were added to the NIS-Flu (https://www.cdc.gov/vaccines/imz-managers/nis/about.html#nis-cim). • Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine to protect against serious illness from COVID-19.
Weekly Cumulative Percentage of Children 6 Months -17 Years Who Are Up to date with COVID-19 Vaccines and Comparison Between 2025-26 and Previous Seasons by Jurisdiction

• Weekly Cumulative Percentage of Children 6 Months–17 Years Who Are Up to Date with COVID-19 Vaccines and Comparison Between 2025–26 and Previous Seasons, by Jurisdiction. • Weekly estimates of COVID-19 vaccination coverage and parental intent for vaccination among children through December 31, 2023, were calculated using data from the National Immunization Survey-Child COVID Module (NIS-CCM) (https://www.cdc.gov/nis/about/index.html). The NIS-CCM was discontinued at the end of 2023 and questions regarding COVID-19 vaccination status and intent were added to the National Immunization Survey-Flu (NIS-Flu) (https://www.cdc.gov/nis/about/index.html). • NIS-CCM and NIS-Flu are national random-digit dial cellular telephone surveys of households with children ages 6 months through 17 years; NIS-Flu is conducted during October-June. The respondent to a NIS-Flu survey is a parent or guardian who said they were knowledgeable about the child’s vaccination history. All estimates are based upon parental report of receipt of vaccination and month of that vaccination. • Weekly comparisons to previous season should take into account differences between seasons in vaccine availability dates. 2023–24 COVID-19 vaccines were first available mid-September 2023, and 2024–25 and 2025–26 COVID-19 vaccines were first available at the end of August 2024 and 2025, respectively. • The NIS-Flu data posted on the dashboard below are currently a few days behind the data that are posted on the Respiratory Illnesses Data Channel (https://www.cdc.gov/respiratory-viruses/data/index.html). This lag is due to the time it takes to review data by geographic and sociodemographic characteristics and summarize the findings.
Weekly Cumulative Percentage of Adults 60 Years and Older Vaccinated with Respiratory Syncytial Virus (RSV) Vaccine by Jurisdiction

Weekly RSV Vaccination Coverage of Adults 60 Years and Older by Jurisdiction • RSV vaccination coverage among adults 60 years and older is assessed through the National Immunization Survey-Adult COVID Module providing weekly RSV vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) • The CDC recommended the RSV vaccine for adults 60 years and older in July 2023. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html)
Weekly Cumulative Percentage of Adults 18 Years and Older Vaccinated with the Updated 2023-24 COVID-19 Vaccine by Jurisdiction

Weekly COVID-19 Vaccination Coverage of Adults 18 Years and Older by Jurisdiction • COVID-19 vaccination coverage among adults 18 years and older is assessed through the National Immunization Survey-Adult COVID Module, providing weekly COVID-19 vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) • Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine for adults ages 18 years and older.
Weekly Cumulative Influenza Vaccine Doses Distributed in the United States

Weekly Cumulative Influenza Vaccine Doses Distributed in the United States, 2016-2021 • Flu vaccine is produced by private manufacturers. For the 2020-2021 season, manufacturers have projected they will provide as many as 194 to 198 million doses of influenza vaccine for the U.S. market. • Additional information is available: https://www.cdc.gov/flu/prevent/vaccine-supply-distribution.htm.
Weekly Cumulative Influenza Vaccination Coverage Map and Comparison Between 2025–26 and 2024–25 by Jurisdiction, Adults 18 Years and Older

• Weekly Influenza Vaccination Coverage Map and Comparison Between 2025-26 and 2024-25 among adults 18 Years and Older by Jurisdiction. • Weekly estimates of influenza vaccination coverage and intent for vaccination among adults are calculated using data from the National Immunization Surveys (NIS)-Fall Respiratory Virus Module (NIS-FRVM). The NIS-FRVM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older. All estimates are based upon self-reported receipt of vaccination and month of that vaccination. • The NIS-FRVM data posted on the dashboard below are currently a few days behind the data that are posted on the Respiratory Illnesses Data Channel. This lag is due to the time it takes to review data by geographic and sociodemographic characteristics and summarize the findings.
Weekly Cumulative Influenza Vaccination Coverage Comparison between Current and Previous Season, Children 6 Months through 17 Years, United States

Weekly Cumulative Influenza Vaccination Coverage Comparison between Current and Previous Season, Children 6 Months through 17 Years, United States • Influenza vaccination coverage among children is assessed through the National Immunization Survey-Flu (NIS-Flu) annually, providing weekly influenza vaccination coverage estimates for children 6 months–17 years based upon parental report. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) o NIS-Flu is a national random-digit-dialed cellular telephone survey of households conducted during the flu season (October-June). • Additional information about NIS-Flu methods and estimates from the 2019-2020 season are available at: https://www.cdc.gov/flu/fluvaxview/coverage-1920estimates.htm. Final estimates for prior seasons and other flu vaccination data are available at CDC’s FluVaxView.: https://www.cdc.gov/flu/fluvaxview/index.htm.
Weekly Cumulative Influenza Vaccination Coverage, Children 6 months through 17 years, United States

Weekly Cumulative Influenza Vaccination Coverage, Children 6 months through 17 years, United States • Archived data are available here: https://data.cdc.gov/resource/vfj2-bfuw • Influenza vaccination coverage among children is assessed through the National Immunization Survey-Flu (NIS-Flu) annually, providing weekly influenza vaccination coverage estimates for children 6 months–17 years based upon parental report. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) o NIS-Flu is a national random-digit-dialed cellular telephone survey of households conducted during the flu season (October-June). • Final estimates for prior seasons and other flu vaccination data are available at CDC’s FluVaxView: https://www.cdc.gov/flu/fluvaxview/index.htm.
Weekly Cumulative Influenza Vaccination Coverage, Children 6 months through 17 years, United States

Weekly Cumulative Influenza Vaccination Coverage, Children 6 months through 17 years, United States • Influenza vaccination coverage among children is assessed through the National Immunization Survey-Flu (NIS-Flu) annually, providing weekly influenza vaccination coverage estimates for children 6 months–17 years based upon parental report. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) o NIS-Flu is a national random-digit-dialed cellular telephone survey of households conducted during the flu season (October-June). • Additional information about NIS-Flu methods and estimates from the 2019-2020 season are available at: https://www.cdc.gov/flu/fluvaxview/coverage-1920estimates.htm.
Weekly Cumulative Influenza Vaccination Coverage by Flu Season, Selected Demographics, and Race and Ethnicity Among Children 6 Months-17 Years, United States

• Weekly Cumulative Influenza Vaccination Coverage by Flu Season, Selected Demographics, and Race and Ethnicity Among 6 Months-17 Years. • Weekly Influenza vaccination coverage and parental intent for vaccination among children is calculated using data from the National Immunization Survey–Flu (NIS–Flu) (https://www.cdc.gov/nis/about/index.html). NIS–Flu is a national random-digit-dialed cellular telephone survey of households with children ages 6 months–17 years conducted during October-June. The respondent to a NIS–Flu survey is a parent or guardian who said they were knowledgeable about the child’s vaccination history. All estimates are based upon parental report of receipt of vaccination and month of that vaccination. • The NIS-Flu data posted on the dashboard below are currently a few days behind the data that are posted on the Respiratory Illnesses Data Channel (https://www.cdc.gov/respiratory-viruses/data/index.html). This lag is due to the time it takes to review data by geographic and sociodemographic characteristics and summarize the findings.
Weekly Cumulative Influenza Vaccination Coverage, by Flu Season and Race/Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years, United States

Weekly Cumulative Influenza Vaccination Coverage, by Flu Season and Race/Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years, United States • Influenza vaccination coverage among Medicare fee-for-service beneficiaries aged ≥65 years is assessed using data files from the Medicare Fee-For-Service (FFS) administrative claims data managed by the Centers for Medicare & Medicaid Services (CMS). • Weekly influenza vaccination coverage estimates were calculated using Kaplan-Meier survival analysis, based on beneficiaries enrolled as of August 1, 2019 and followed through May 31, 2020 for 2019-20 flu season; and enrolled as of August 1, 2020 and followed through May 31, 2021 for 2020-21 flu season; and enrolled as of Aug 1, 2021 and followed through May 28, 2022 for the 2021-22 flu season. • Additional information about data source is available https://www2.ccwdata.org/web/guest/home/.
Weekly Cumulative Influenza Vaccination Coverage, by Flu Season and Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years, United States, Data Source: Centers for Medicare & Medicaid Services Chronic Conditions Warehouse

• Influenza vaccination coverage among Medicare fee-for-service beneficiaries 65 years and older is assessed using data files from the Medicare Fee-For-Service (FFS) administrative claims data managed by the Centers for Medicare & Medicaid Services (CMS). • Weekly influenza vaccination coverage estimates were calculated using Kaplan-Meier survival analysis, based on beneficiaries enrolled as of August 1 at the start of each flu season (example: Aug 1, 2021) until the end of the current season reporting time period or the end of May the following year for prior seasons (example: May 28, 2022). Influenza vaccines received since August 1 of each season, among adults who were 65 years or older as of the end of the first year of the season (e.g., December 31, 2025 for the 2025–26 season), were included.
Weekly Cumulative Influenza Vaccination Coverage and Comparison Between 2025–26 and Previous Seasons± by Jurisdiction, Children 6 Months–17 Years, United States

• Weekly Cumulative Influenza Vaccination Coverage and Comparison Between 2025–26 and Previous Seasons by Jurisdiction, Children 6 Months–17, United States. • Weekly Influenza vaccination coverage and parental intent for vaccination among children is calculated using data from the National Immunization Survey–Flu (NIS–Flu) (https://www.cdc.gov/nis/about/index.html). NIS–Flu is a national random-digit-dialed cellular telephone survey of households with children ages 6 months–17 years conducted during October-June. The respondent to a NIS–Flu survey is a parent or guardian who said they were knowledgeable about the child’s vaccination history. All estimates are based upon parental report of receipt of vaccination and month of that vaccination. • The NIS-Flu data posted on the dashboard below are currently a few days behind the data that are posted on the Respiratory Illnesses Data Channel (https://www.cdc.gov/respiratory-viruses/data/index.html). This lag is due to the time it takes to review data by geographic and sociodemographic characteristics and summarize the findings.
Weekly Cumulative Influenza Vaccination Coverage, Adults 18 and Older, United States

Weekly Cumulative Influenza Vaccination Coverage, Adults 18 and Older, United States • Influenza vaccination coverage among adults is assessed through the National Immunization Survey-Adult COVID Module providing weekly influenza vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) • NIS-ACM was started in April 2021 to survey adults 18 years and older COVID-19 vaccination uptake and vaccine confidence. • Final estimates for prior seasons and other flu vaccination data are available at CDC’s FluVaxView: https://www.cdc.gov/flu/fluvaxview/index.htm.
Weekly Cumulative Estimated Number of Updated 2023-24 COVID-19 Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States, Data Source(s): IQVIA Pharmacy and Physician Medical Office Claims

Weekly Cumulative Estimated Number of Updated 2023-24 COVID-19 Vaccinations Administered in Pharmacies and Physical Medical Offices, Adults 18 Years and Older, United States • Estimated number of updated COVID-19 vaccinations among adults 18 years and older is assessed through IQVIA (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, food stores, and independent pharmacies) and physician medical offices. • Starting in September 2023, the CDC recommended the updated 2023-2024 COVID-19 vaccine for adults ages 18 years and older.
Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Retail Pharmacies and Physicians’ Medical Offices, Adults 60 to 74 Years and 75 years and older, United States

•Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Retail Pharmacies and Physicians’ Medical Offices, Adults 60 to 74 Years and 75 Years and Older, United States • Estimated Number of RSV vaccinations among adults 60 years and older is assessed through IQVIA (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, food stores, and independent pharmacies) and physician medical offices.
Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Retail Pharmacies and Physicians' Medical Offices, Adults 50 to 74 Years and 75 years and older, United States

• Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Retail Pharmacies and Physicians’ Medical Offices, Adults 50–74 Years and 75 Years and Older, United States • In June 2023, the Advisory Committee on Immunization Practices (ACIP) voted to recommend that adults aged ≥60 years may receive a single dose of an RSV vaccine, using shared clinical decision-making. In June 2024, the ACIP voted to recommend a single dose of RSV vaccine for all adults 75 years and older and adults 60–74 years who are at increased risk for severe RSV disease.† On June 26, 2024, CDC adopted these recommendations. In April 2025, ACIP recommended that adults 50–59 years who are at increased risk for severe RSV disease were added to the previous recommendation. This recommendation was adopted by the HHS Secretary on June 25, 2025. The data below capture the number of RSV doses administered to adults 50 years and older.† • The projected pharmacy estimates are based on IQVIA‡,§ Longitudinal Prescription Claims (LRx) and vaccinations administered in retail pharmacies (including chain, mass merchandise, food stores, and independent pharmacies). ± The projected physicians’ medical offices estimates are based on IQVIA’s Medical Claims (Dx).^ • Vaccinations administered in workplaces, community locations, long-term care settings, and other medical settings such as public health clinics are not represented in these data.
Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 60 years and older, United States

Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 60 Years and Older, United States • Estimated Number of RSV vaccinations among adults 60 years and older is assessed through IQVIA (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, food stores, and independent pharmacies) and physician medical offices. • Starting in September 2023, the CDC recommended the RSV vaccine for adults 60 years and older.
Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Retail Pharmacies and Physicians’ Medical Offices, by Influenza Season and Age Group, Adults 18 years and older, United States

• Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Retail Pharmacies and Physicians’ Medical Offices, by Flu Season, Adults 18 Years and Older, United States. • The projected pharmacy estimates are based on IQVIA†,‡ Longitudinal Prescription Claims (LRx) and vaccinations administered in retail pharmacies (including chain, mass merchandise, food stores, and independent pharmacies).§ The projected physicians’ medical offices estimates are based on IQVIA’s Medical Claims (Dx)±. • Vaccinations administered in workplaces, community locations, long-term care settings, and other medical settings such as public health clinics are not represented in these data.
Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States (ARCHIVED)

Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States - Since 2019, CDC has been exploring use of data obtained from (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, food stores, and independent pharmacies) and physician medical offices. These data are being presented publicly for the first time this season; further evaluations of these data are underway. - The pharmacy data include flu vaccinations that were billed for (i.e. claims) or paid by cash. Medical office data are claims based. - The sampled pharmacies and physician medical offices and the captured volume of transactions represent approximately 92% and 82% of influenza vaccines administered nationally, respectively. - Vaccinations administered in other settings such as workplaces and community settings are not included in these data. - Weekly Number of Influenza Vaccinations Administered, in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States, Data Source(s): IQVIA Pharmacy and Physician Medical Office Claims.
Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States

Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States - Archived data are here: https://data.cdc.gov/resource/uxgd-cqqc - CDC is exploring use of data obtained from IQVIA§ (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, food stores, and independent pharmacies) and physician medical offices. - These projected pharmacy estimates include flu vaccinations that were billed for (i.e. claims) or paid by cash. Medical office projected estimates are claims-based only. - The sampled pharmacies and physician medical offices and the captured volume of transactions represent approximately 92% and 82% of influenza vaccines administered nationally, respectively. - Vaccinations administered in other settings such as workplaces and community settings are not included in these data. *National estimates for pharmacies and medical offices include vaccinations administered in 50 states and DC. National estimates for medical office vaccinations do not include doses where geographic information (i.e. which state the dose was administered in) was missing. Pharmacy data are through Friday of each week and medical office data are through Saturday of each week. Week ending dates for prior seasons are aligned with the current season’s week ending dates. § 1) King, L. M., Bartoces, M., Fleming-Dutra, K. E., et. al, L. A. (2020). Changes in US outpatient antibiotic prescriptions from 2011–2016external icon. Clinical Infectious Diseases, 70(3), 370-377. 2) McLaughlin, J. M., Swerdlow, D. L., Khan, F., et. Al (2019). Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United Statesexternal icon. Human vaccines & immunotherapeutics, 15(4), 841-849.
Weekly Cumulative Estimated Number of COVID-19 Vaccinations Administered in Retail Pharmacies and Physician Medical Offices, Adults 18 years and older, by Season and Age Group, United States

•Weekly Cumulative Estimated Number of COVID-19 Vaccinations Administered in Retail Pharmacies and Physician Medical Offices, Adults 18 Years and Older, United States •The projected pharmacy estimates are based on IQVIA†,‡ Longitudinal Prescription Claims (LRx) and vaccinations administered in retail pharmacies (including chain, mass merchandise, food stores, and independent pharmacies). § The projected physicians’ medical offices estimates are based on IQVIA’s Medical Claims (Dx). ± •Vaccinations administered in workplaces, community locations, long-term care settings, and other medical settings such as public health clinics are not represented in these data. • Weekly comparisons to previous seasons should take into account differences between seasons in vaccine availability dates. 2023–24 COVID-19 vaccines were first available mid-September 2023, and 2024–25 and 2025–26 COVID-19 vaccines were first available at the end of August 2024 and 2025, respectively. ^